Observational Study
Copyright ©The Author(s) 2024.
World J Hepatol. Jan 27, 2024; 16(1): 54-64
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.54
Table 2 Comparison of demographic, clinical, and laboratory characteristics among metabolic associated fatty liver disease with a single metabolic condition alone
CharacteristicObesity alone (n = 61)Lean MD (n = 34)DM alone (n = 15)P value
Overall
Obesity
vs lean MD
Obesity
vs DM
Lean MD
vs DM
Age (yr)41.72 ± 10.0345.53 ± 10.6050.73 ± 9.040.0050.0820.0020.116
BMI (kg/m2)32.33 ± 4.6624.86 ± 1.6324.81 ± 1.58< 0.001< 0.001< 0.0010.965
Female Gender (%)51 (83.6)23 (67.6)11 (73.3)0.1910.0720.3580.691
Hypertension (%)8 (13.1)6 (17.6)0 (0.0)0.2300.5510.1380.082
NFS score-2.86 ± 1.74-2.50 ± 1.40-1.61 ± 0.810.0170.3090.0050.054
Fib-4 score0.68 ± 0.350.92 ± 0.560.95 ± 0.480.0270.0500.0170.761
DBP84.26 ± 15.4187.03 ± 10.4385.73 ± 8.610.4990.2620.5480.728
SBP131.03 ± 17.46135.82 ± 19.94134.60 ± 12.890.3060.2550.1810.828
Platelet count314.85 ± 97.95275.44 ± 81.92245.40 ± 50.700.0040.0320.0020.298
Total cholesterol176.91 ± 37.71190.97 ± 49.33175.00 ± 41.930.3360.1600.8790.313
LDL120.53 ± 35.87126.76 ± 44.83130.73 ± 44.800.6260.4730.4330.688
HDL42.50 ± 11.1439.96 ± 21.7142.30 ± 8.730.0260.0100.6780.079
TG135.75 ± 57.72269.02 ± 120.03176.13 ± 132.33< 0.001< 0.0010.2130.001
Total bilirubin0.52 ± 0.430.55 ± 0.240.50 ± 0.220.1710.0550.6980.467
Direct bilirubin0.19 ± 0.100.18 ± 0.080.20 ± 0.090.6130.4800.5490.424
Serum albumin4.41 ± 0.344.40 ± 0.334.44 ± 0.590.7310.7790.5260.428
ALT33.89 ± 30.4743.94 ± 28.4134.13 ± 19.040.0430.0160.2640.288
AST25.75 ± 15.3834.76 ± 29.2626.33 ± 13.600.0860.0250.7240.302
GGT32.32 ± 21.2237.85 ± 20.3739.15 ± 22.280.1390.0830.1690.849
ALP113.61 ± 68.86107.03 ± 39.59116.00 ± 58.230.9480.8800.7340.888
HbA1c5.56 ± 0.465.77 ± 0.488.03 ± 1.71< 0.0010.006< 0.001< 0.001